About two-thirds of tumours of adult human lymphoid tissue originate from B cells; one-fifth derive from T cells; one-eighth are undefinable, using markers currently available; and fewer than one in a 100 are truely histiocytic, showing markers associated with monocytes (Lukes et al., 1978) . B cells can be demonstrated in suitable tissue sections since they possess either surface or intracytoplasmic immunoglobulin. Evidence of monoclonality can be deduced from the pattern of immunoglobulin light chain staining (Warnke and Levy, 1978) . Techniques are not yet available to enable similarly detailed studies to be performed on human T cells in tissue sections where structural relationships can be defined. The emphasis in this paper consequently is on B cell malignancies.
B cell malignancies
To understand the complexities of distribution of cells in these diseases the heterogeneity of physiological B cells must be considered first. Precursor B cells develop in the bone marrow (Davies, 1969) , and, in experimental animals, in the fetal liver (Cooper, 1975) . Recently these cells have been shown to contain intracytoplasmic IgM, and to be able to reconstitute animals which have been deprived of more mature B cells. After leaving the sites of primary B cell development the cells are found to exhibit surface immunoglobulin (Cooper et al., 1977) . Many of these B cells form part of the pool of small lymphocytes, which are engaged in a constant recirculation via the lymph and blood between the secondary lymphoid organs (lymphoid follicles and Peyer's patches of the lamina propria of the gut, lymph nodes, and white pulp of the spleen) (reviewed by Ford, 1975) .
Some B-cells, however, are situated in sites where migration is less obvious-for example (1) the marginal zone of the spleen as well as in the equivalent areas in lymph nodes and gut-associated lymphoid tissue, and (2) the secondary follicles (or 'germinal centres'). The second of these is of particular clinical interest, because follicle centre cell tumours are relatively common and appear to represent neoplastic transformation of germinal centre B cells (Lukes and Collins, 1973) .
The final stage of B cell development follows stimulation by antigen whereby the cells mature into antibody-producing cells (Reviewed by Lennert, 1978 proportion of cells with the capacity to mature into antibody-producing cells. In such tumours a paraprotein may be detected in the serum or urine.
The converse is seen in some cases presenting as multiple myeloma. In these the lymphocytic component can be detected by demonstrating idiotypic immunoglobulin synthesis by a clone of circulating small lymphocytes (Mellstedt et al., 1974; Abdou and Abdou, 1975) .
(3) Metastasis of end-stage B cell tumours Localised tumours may arise from B cells after they have reached the end point of their migration. The tumours may be classified morphologically as lymphoplasmacytoid, or plasma cell tumours, or as immunoblastic sarcoma. They may metastasise to characteristic secondary sites. In this instance a I to IV clinical staging has prognostic and therapeutic implications.
LYMPHOCYTIC LYMPHOMA Early in the disease patients present typically with nodal or splenic enlargement. The overall architecture is preserved but there is a selective increase in numbers in one cellular component. In the case of B cell neoplasms this can often be demonstrated by sensitive immunoperoxidase techniques (Taylor and Mason, 1974) (Fig. 1) .
T cell lymphocytic lymphoma, which in England and America is much rarer than the B cell equivalent, may similarly show expansion in areas predominantly populated by T cells-for example, the periarteriolar lymphatic sheath in the spleen. In the case of T cells early involvement is difficult to detect because therẽ~~~~~.~~~~~~~~~~~~~~. (Rilke et al., 1978) .
The T cells of mycosis fungoides may represent another example of homing. In this condition tumour often invades multiple areas of skin and many years may elapse before lymph node or visceral involvement becomes evident. It is generally held that the Sezary syndrome is a leukaemic variant of mycosis fungoides. In this context it is of interest that a number of cases of T cell lymphocytic leukaemia that show a predeliction for skin have been reported (Brouet et al., 1975) . To what extent T cells home physiologically to skin is at present speculative.
PLASMA CELL TUMOURS AS NEOPLASTIC TRANSFORMATION OF LYMPHOCYTIC CELLS
In rare instances chronic lymphocytic leukaemia has been shown to develop into plasma cell leukaemia (leukaemic myelomatosis)-for example, case 3 in Zawadzki et al. (1978) , who cite 10 other cases with simultaneously existing chronic lymphatic leukaemia and multiple myeloma. Rather more often circulating small lymphocytes have been shown to carry the idiotypic immunoglobulin of the paraprotein and to be able to resynthesise it after its removal by trypsin digestion (Mellstedt et al., 1974; Abdou and Abdou, 1975 (Fig. 2) .
Very much more rarely fewer plasma cells of the paraprotein light chain type may be present than of the alternative light chain. This has been noted also by others . Such an appearance may indicate suppression of physiological plasma cells with light chains of the myeloma type in a sample taken from an unaffected area. In the cases of the diffusely distributed malignant cells it is more difficult to envisage such a pattern arising from division within the marrow than the possibility that the cells have migrated into the marrow at various points as more immature forms.
Results such as these suggest that some B cell 2b Fig. 2 (a (Crabbe and Heremans, 1966 ), yet in only three rectal biopsies from 214 myeloma patients has there been evidence of involvement, while random sternal aspirates have shown unequivocal involvement in 95 % of cases.
In contrast, other B cell neoplasms presenting outside the gut often show tumour involvement in random rectal mucosal biopsies. In the Oxford nonHodgkin's lymphoma series this is currently highest for follicle centre cell tumours at about 40 % with an incidence of around 20 % overall in non-Hodgkin's lymphoma.
FOLLICLE CENTRE CELL TUMOURS Lukes and Collins (1973) proposed that some tumours, often described by others as 'nodular lymphomas', might represent the neoplastic equivalent of reactive, secondary follicles. Follicle centre cell tumours, they suggest, are composed of 'defective immune cells that function in, migrate to, and arise in tissues similar in varying degrees to their normal counterparts' (Lukes et al., 1978) (Fig. 3) . Warnke and Levy (1978) studied 22 patients with follicular lymphoma by analysis of the light and heavy chains on the tumour cells. They review the evidence that a single cell could give rise to progeny that produce immunoglobulin of different heavy chain classes, but that the products of one clone all show a single variable segment of both heavy chains and a single light chain-constant region of either kappa or lambda type. They conclude that monoclonality may be inferred from the uniformity of light chain type.
All but two out of these 22 patients showed positive immunofluorescent staining for immunoglobulin within the follicles. There was light chain restriction in each case, which was regarded as evidence of monoclonality in the tumour. Just over half of their cases showed a normal ratio of about 2:1 kappa to lambda positive cells in the interfollicular regions. Just under a half showed diffuse areas of infiltration by cells of the same light chain type as those in the neoplastic follicles, although not always to the total exclusion of cells showing the alternative light chain.
Our experience with the immunoperoxidase technique applied to routinely processed paraffin sections is broadly similar, although there may often be doubt about the significance of the low level of follicular staining and interfollicular monoclonal infiltration is rare. R. L Vanhegan Warnke and Levy (1978) Rosenberg (1975) has shown that the bone marrow is involved on presentation in as many as 85 % of patients with follicular lymphoma. Goudie et al. (1974) (Isaacson and Wright, 1978b 
